- Home
- INTA vs AXSM Comparison
INTA vs AXSM Comparison
Compare INTA & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTA
- AXSM
- Stock Information
- Founded
- INTA 2000
- AXSM 2012
- Country
- INTA United States
- AXSM United States
- Employees
- INTA N/A
- AXSM N/A
- Industry
- INTA Computer Software: Prepackaged Software
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- INTA Technology
- AXSM Health Care
- Exchange
- INTA Nasdaq
- AXSM Nasdaq
- Market Cap
- INTA 3.8B
- AXSM 4.4B
- IPO Year
- INTA 2021
- AXSM 2015
- Fundamental
- Price
- INTA $56.13
- AXSM $93.18
- Analyst Decision
- INTA Strong Buy
- AXSM Strong Buy
- Analyst Count
- INTA 12
- AXSM 14
- Target Price
- INTA $53.82
- AXSM $124.93
- AVG Volume (30 Days)
- INTA 675.9K
- AXSM 518.8K
- Earning Date
- INTA 11-04-2024
- AXSM 11-12-2024
- Dividend Yield
- INTA N/A
- AXSM N/A
- EPS Growth
- INTA N/A
- AXSM N/A
- EPS
- INTA N/A
- AXSM N/A
- Revenue
- INTA $447,753,000.00
- AXSM $338,457,000.00
- Revenue This Year
- INTA $17.72
- AXSM $40.67
- Revenue Next Year
- INTA $14.96
- AXSM $69.27
- P/E Ratio
- INTA N/A
- AXSM N/A
- Revenue Growth
- INTA 20.07
- AXSM 51.47
- 52 Week Low
- INTA $30.36
- AXSM $56.66
- 52 Week High
- INTA $60.89
- AXSM $105.00
- Technical
- Relative Strength Index (RSI)
- INTA 61.25
- AXSM 63.56
- Support Level
- INTA $48.58
- AXSM $88.74
- Resistance Level
- INTA $60.89
- AXSM $105.00
- Average True Range (ATR)
- INTA 2.32
- AXSM 3.35
- MACD
- INTA 0.23
- AXSM 0.92
- Stochastic Oscillator
- INTA 61.36
- AXSM 59.25
About INTA Intapp Inc.
Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital, investment banking, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.